跳至主要内容
临床试验/ISRCTN51868986
ISRCTN51868986已完成3 期

A multicentre, prospective, randomised, double-blind, placebo-controlled, international study to assess the effects of 2 g per day of strontium ranelate versus placebo on the time to fracture healing in osteoporotic men and women

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 217 人开始时间: 2010年7月5日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
217

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Osteoporotic men and osteoporotic post-menopausal women
  • 2. Aged superior or equal to 50 years
  • 3. Patient with a fracture of the distal radius (Colles' fracture)

排除标准

  • 1. Fractures not meeting inclusion criteria (including displaced radius fractures)
  • 2. Concomitant treatments likely to interfere with bone metabolism

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验

Unknown
3 期
Atrial Fibrillation Management: CardiaCare™ Wearable Homecare Study ?
CTRI/2023/09/057605Dr Reddys Laboratories Limited
进行中(未招募)
1 期
A prospective, multicentre, randomised, double-blind, placebo-controlled, phase 2a study to compare the efficacy and the safety of 24-week treatment with masitinib versus placebo in patients with severe Chronic Obstructive Pulmonary Disease (COPD)Patients with severe COPD
EUCTR2012-005586-13-ESAB SCIENCE30
进行中(未招募)
不适用
A study of a new iron medication for people with Crohn's Disease that is in remission and anaemia (low number of healthy red blood cells), who cannot use other oral iron medications either because they do not work, or because they cause side effects. (AEGIS 2)Iron deficiency anaemia in quiescent Crohn's DiseaseMedDRA version: 14.1Level: PTClassification code 10022972Term: Iron deficiency anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2010-023589-39-ATIron Therapeutics (Switzerland) AG60
进行中(未招募)
1 期
clinical trial to assess efficacy and safety of masitinib in the treatment of Chronic Obstructive Pulmonary DiseaseSevere Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 20.0 Level: PT Classification code 10009033 Term: Chronic obstructive pulmonary disease System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2012-005586-13-SKAB Science45
进行中(未招募)
1 期
Evaluation of masitinib in acute ischemic strokepatients suffering from Acute Ischemic StrokeMedDRA version: 18.1Level: LLTClassification code 10023027Term: Ischaemic stroke NOSSystem Organ Class: 100000004852
EUCTR2010-020603-79-SKAB Science48